Lexeo Therapeutics, Inc.
LXEONasdaqCIK 1907108HealthcareFiscal year ends Dec 31
Reports and events: 58 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2916:20 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-407555 |
| 2026-09-2207:08 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-397221 |
| 2026-08-1207:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-345724 |
| 2026-08-1207:02 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-345722 |
| 2026-06-2917:06 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-288703 |
| 2026-06-1507:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-270275 |
| 2026-05-1107:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-215678 |
| 2026-05-1107:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-215674 |
| 2026-04-3007:01 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001193125-26-193930 |
| 2026-04-3007:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-193927 |
| 2026-03-3017:39 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-132085 |
| 2026-03-3017:30 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-131792 |
| 2026-02-0516:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-039425 |
| 2026-01-2707:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-023339 |
| 2026-01-1211:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-010091 |
| 2025-11-0507:41 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-265757 |
| 2025-11-0507:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265755 |
| 2025-10-1717:26 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-242652 |
| 2025-10-0706:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-232514 |
| 2025-08-1407:33 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108427 |
| 2025-08-1407:31 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-108426 |
| 2025-06-3016:47 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-091671 |
| 2025-05-2707:32 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-077377 |
| 2025-05-1518:22 ET | 10-Q/A | Quarterly report, amendedPeriod 2025-03-31 | 0000950170-25-071709 |
| 2025-05-1207:03 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-068536 |
| 2025-05-1207:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-068534 |
| 2025-04-2816:46 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0000950170-25-059375 |
| 2025-04-0706:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-051345 |
| 2025-03-2407:03 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-043486 |
| 2025-03-2407:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-043485 |
| 2025-01-1307:35 ET | 8-K | 8.01 Other events | 0000950170-25-004566 |
| 2024-12-1907:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-138224 |
| 2024-11-1307:33 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125943 |
| 2024-11-1307:31 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-125940 |
| 2024-10-3006:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-118569 |
| 2024-10-0916:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-113764 |
| 2024-08-1207:02 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095057 |
| 2024-08-1207:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095054 |
| 2024-07-1507:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-083386 |
| 2024-07-0807:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-081942 |
| 2024-06-2807:33 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-078774 |
| 2024-05-0907:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056260 |
| 2024-05-0907:02 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056247 |
| 2024-04-2607:55 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0000950170-24-048662 |
| 2024-04-2208:22 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-046197 |
| 2024-04-2208:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950123-24-003417 |
| 2024-04-1607:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-044598 |
| 2024-04-0908:01 ET | S-1 | Registration statement | 0001193125-24-090233 |
| 2024-03-1116:11 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-029249 |
| 2024-03-1109:29 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-028941 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:31 ET. Listed shows no prices and gives no investment advice.